Bristol-Myers Squibb Overview
Bristol-Myers Squibb Target Price
Analysts' 12-month price predictions for BMY.
Share Price
$43.7
Average Target Price
$55.00
25.9% upside
25.9% upside1 analysts in the last 4 months
High: $55 | Low: $55
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-01-30 | Deutsche BankJames Shin | $55 | 25.9% upside |  |
| 2023-11-27 | BMO CapitalEvan Seigerman | $60 | 37.3% upside | |
| 2023-10-12 | Leerink PartnersDavid Risinger | $66 | 51% upside | |
| 2023-09-06 | Cantor FitzgeraldLouise Chen | $75 | 71.6% upside | |
| 2022-05-18 | Wells FargoMohit Bansal | $70 | 60.2% upside | |
| 2022-05-02 | BMO Capital | $92 | 110.5% upside | |
| 2022-05-02 | Barclays | $68 | 55.6% upside | |
| 2022-05-02 | GuggenheimSeamus Fernandez | $80 | 83.1% upside | |
| 2022-05-02 | BMO CapitalEvan Seigerman | $87 | 99.1% upside | |
| 2022-04-11 | Morgan StanleyTerence Flynn | $64 | 46.5% upside | |
| 2022-04-04 | BMO CapitalEvan Seigerman | $81 | 85.4% upside | |
| 2022-03-28 | Morgan StanleyMatthew Harrison | $66 | 51% upside | |
| 2022-03-17 | BMO CapitalEvan David Seigerman | $74 | 69.3% upside | |
| 2021-10-28 | BarclaysCarter Gould | $66 | 51% upside | |
| 2021-10-25 | CitigroupAndrew Baum | $75 | 71.6% upside | |
| 2021-09-20 | GuggenheimSeamus Fernandez | $82 | 87.6% upside | |
| 2021-09-07 | Societe GeneraleJustin Smith | $85 | 94.5% upside | |
| 2021-07-27 | Bank of America SecuritiesGeoff Meacham | $78 | 78.5% upside | |